Provided by Tiger Fintech (Singapore) Pte. Ltd.

Urogen Pharma Ltd.

11.51
+0.10000.88%
Post-market: 11.510.00000.00%16:05 EDT
Volume:484.89K
Turnover:5.59M
Market Cap:530.55M
PE:-3.89
High:11.75
Open:11.49
Low:11.20
Close:11.41
Loading ...
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 18, 2024

Major Issues Report

Form 8-K - Current report
Jan 02, 2024

Major Issues Report

Form 8-K - Current report
Dec 29, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 28, 2023

Correspondence

Form CORRESP - Correspondence
Nov 15, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 16, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 13, 2023

Correspondence

Form CORRESP - Correspondence
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jul 27, 2023

Major Issues Report

Form 8-K - Current report